IWC
GILD icon

Integrated Wealth Concepts’s Gilead Sciences GILD Stock Holding History

Integrated Wealth Concepts’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.01M Buy
35,972
+20,046
+126% +$2.81M 0.04% 427
2025
Q4 		$1.95M Sell
15,926
-14,155
-47% -$1.72M 0.02% 537
2025
Q3 		$3.34M Sell
30,081
-1,440
-5% -$164K 0.03% 499
2025
Q2 		$3.49M Buy
31,521
+4,452
+16% +$474K 0.04% 441
2025
Q1 		$3.03M Buy
27,069
+382
+1% +$39.4K 0.04% 465
2024
Q4 		$2.47M Buy
26,687
+1,194
+5% +$108K 0.03% 494
2024
Q3 		$2.14M Sell
25,493
-251
-1% -$19.2K 0.03% 525
2024
Q2 		$1.77M Buy
25,744
+926
+4% +$61.8K 0.02% 550
2024
Q1 		$1.82M Buy
24,818
+219
+0.9% +$16.8K 0.03% 555
2023
Q4 		$1.99M Sell
24,599
-3,616
-13% -$281K 0.03% 483
2023
Q3 		$2.11M Buy
28,215
+338
+1% +$26K 0.04% 434
2023
Q2 		$2.15M Sell
27,877
-4,220
-13% -$337K 0.04% 434
2023
Q1 		$2.66M Buy
32,097
+14,376
+81% +$1.19M 0.05% 322
2022
Q4 		$1.52M Sell
17,721
-1,451
-8% -$115K 0.04% 381
2022
Q3 		$1.18M Sell
19,172
-382
-2% -$24.1K 0.04% 389
2022
Q2 		$1.21M Sell
19,554
-3,944
-17% -$244K 0.04% 395
2022
Q1 		$1.4M Buy
23,498
+3,051
+15% +$195K 0.04% 322
2021
Q4 		$1.49M Buy
20,447
+1,555
+8% +$107K 0.04% 315
2021
Q3 		$1.32M Buy
18,892
+6,690
+55% +$470K 0.04% 328
2021
Q2 		$840K Buy
12,202
+276
+2% +$18.4K 0.03% 399
2021
Q1 		$771K Sell
11,926
-439
-4% -$28.3K 0.03% 355
2020
Q4 		$720K Buy
12,365
+25
+0.2% +$1.51K 0.03% 319
2020
Q3 		$780K Buy
12,340
+5,117
+71% +$355K 0.05% 257
2020
Q2 		$556K Buy
7,223
+3,016
+72% +$231K 0.04% 264
2020
Q1 		$315K Sell
4,207
-1,248
-23% -$86.2K 0.03% 302
2019
Q4 		$354K Buy
5,455
+939
+21% +$61.1K 0.03% 332
2019
Q3 		$286K Sell
4,516
-506
-10% -$33.1K 0.03% 322
2019
Q2 		$322K Buy
+5,022
New +$330K 0.04% 256
2018
Q4 		– Sell
-2,580
Closed -$201K – 277
2018
Q3 		$201K Buy
+2,580
New +$195K 0.06% 243

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Integrated Wealth Concepts's GILD Position: Q1 2026 in Review

Integrated Wealth Concepts increased its Gilead Sciences (GILD) stake by 126% in Q1 2026, buying an estimated $2.81M and bringing the position to 35,972 shares worth $5.01M. The position accounts for 0.04% of the portfolio, ranked #427.

Integrated Wealth Concepts first reported a position in GILD in Q3 2018 and has held it in 29 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Integrated Wealth Concepts held 35,972 shares of Gilead Sciences worth $5.01M as of Q1 2026.
  • Integrated Wealth Concepts bought 20,046 Gilead Sciences shares in Q1 2026, an estimated $2.81M.
  • Gilead Sciences made up 0.04% of Integrated Wealth Concepts's portfolio in Q1 2026, its #427 holding.
  • Integrated Wealth Concepts first reported a position in Gilead Sciences in Q3 2018 and has held it in 29 quarters since.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Integrated Wealth Concepts's 13F filing for Q1 2026, filed 15 May 2026.